Moberg Pharma AB (publ)
STO:MOB
Moberg Pharma AB (publ)
STO:MOB
Price:
9.15
SEK
-0.22%
Market Cap:
kr445.7m
Balance Sheet
Balance Sheet Decomposition
Moberg Pharma AB (publ)
Moberg Pharma AB (publ)
Balance Sheet Decomposition is not available for
Moberg Pharma AB (publ)
Moberg Pharma AB (publ)
Balance Sheet
Moberg Pharma AB (publ)
Moberg Pharma AB (publ)
Currency: SEK
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
19
|
103
|
126
|
61
|
293
|
|
| Cash Equivalents |
19
|
103
|
126
|
61
|
293
|
|
| Total Receivables |
2
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
2
|
1
|
1
|
1
|
1
|
|
| Inventory |
0
|
0
|
0
|
7
|
4
|
|
| Other Current Assets |
145
|
1
|
1
|
1
|
2
|
|
| Total Current Assets |
167
|
105
|
128
|
69
|
300
|
|
| PP&E Net |
7
|
5
|
6
|
5
|
4
|
|
| PP&E Gross |
7
|
5
|
6
|
5
|
4
|
|
| Accumulated Depreciation |
2
|
2
|
2
|
2
|
2
|
|
| Intangible Assets |
296
|
327
|
408
|
532
|
306
|
|
| Other Long-Term Assets |
11
|
15
|
23
|
28
|
96
|
|
| Total Assets |
481
N/A
|
451
-6%
|
564
+25%
|
635
+12%
|
706
+11%
|
|
| Liabilities | ||||||
| Accounts Payable |
3
|
5
|
17
|
7
|
4
|
|
| Accrued Liabilities |
27
|
7
|
7
|
9
|
9
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
3
|
3
|
2
|
1
|
2
|
|
| Other Current Liabilities |
48
|
1
|
1
|
3
|
2
|
|
| Total Current Liabilities |
80
|
16
|
27
|
21
|
17
|
|
| Long-Term Debt |
5
|
1
|
4
|
3
|
3
|
|
| Minority Interest |
8
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
93
N/A
|
17
-82%
|
31
+83%
|
24
-22%
|
19
-20%
|
|
| Equity | ||||||
| Common Stock |
2
|
4
|
10
|
28
|
47
|
|
| Retained Earnings |
307
|
302
|
317
|
339
|
594
|
|
| Additional Paid In Capital |
693
|
731
|
841
|
921
|
1 234
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
388
N/A
|
434
+12%
|
534
+23%
|
611
+14%
|
687
+12%
|
|
| Total Liabilities & Equity |
481
N/A
|
451
-6%
|
564
+25%
|
635
+12%
|
706
+11%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
7
|
7
|
15
|
28
|
47
|
|
Switch to:
Switch to:
See Also
Discover More
